Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine

Cell Immunol. 1999 Nov 1;197(2):145-50. doi: 10.1006/cimm.1999.1566.

Abstract

Macrolide antibiotics have unique immunomodulatory actions apart from their antimicrobial properties. We examined the effect of erythromycin (EM), a 14-member macrolide, on the immune response to a DNA vaccine that induces a T-helper-1 (Th1)-biased immune response through a Th1-promoting adjuvant effect of unmethylated CpG motifs within plasmid DNA. EM enhanced Th1 responses in plasmid DNA-immunized mice as measured by antigen-specific IgG2a antibody production, interferon-gamma production by antigen-specific CD4(+) T cells, and cytotoxic T lymphocyte responses. EM augmented the accessory cell activity of unmethylated CpG DNA-stimulated antigen-presenting cells (APCs), suggesting that EM enhances Th1 responses to a DNA vaccine, possibly through augmentation of accessory cell activity of APCs stimulated with CpG motifs within plasmid DNA.

MeSH terms

  • Adjuvants, Immunologic*
  • Animals
  • Anti-Bacterial Agents / immunology*
  • Anti-Bacterial Agents / pharmacology
  • Antigen-Presenting Cells / drug effects
  • Antigen-Presenting Cells / immunology
  • CpG Islands
  • Erythromycin / immunology*
  • Erythromycin / pharmacology
  • Female
  • Josamycin / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Spleen / cytology
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology
  • Vaccines, DNA / immunology*
  • beta-Galactosidase / genetics

Substances

  • Adjuvants, Immunologic
  • Anti-Bacterial Agents
  • Vaccines, DNA
  • Erythromycin
  • beta-Galactosidase
  • Josamycin